As part of the weekly research here at The Acquirer’s Multiple we’re always interested in investing gurus who hold the same stocks that appear in our Acquirer’s Multiple Stock Screeners, based on their latest 13F’s. Investors such as Warren Buffett, Joel Greenblatt, Carl Icahn, Jim Simons, Prem Watsa, Jeremy Grantham, Seth Klarman, Ray Dalio, and Howard Marks.
While doing this research we’ve also uncovered a number of common stocks that investing gurus have recently bought, or continuing to hold in their portfolios, according to their latest 13f’s. So we’re now providing a new weekly feature article called ‘One Stock Superinvestors Are Buying Or Holding’. This week we’ll take a look at:
Teva Pharmaceutical Industries Ltd (NYSE: TEVA)
Headquartered in Israel, Teva Pharmaceutical is the largest generic drug manufacturer in the world. The company was formed in 1901 and has a portfolio of more than 3,500 medicines–roughly 1 out of 9 generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva’s generic drug sales represent slightly over half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending Food and Drug Administration approval.
A quick look at the price chart below for Teva Pharmaceutical shows us that the stock is down 19% in the past twelve months.
Superinvestors who recently bought, or continue to hold Teva Pharmaceutical stock in their portfolios include:
Warren Buffett – 42,789,295
David Abrams – 24,046,356
Bill Miller – 10,554,065
Jeremy Grantham – 1,993,900
Ken Griffin – 1,953,066
Steve Cohen – 1,568,700
Cathie Wood – 499,844
Mario Gabelli – 168,400
Lee Ainslie – 155,841
Jim O’Shaughnessy – 88,170
For all the latest news and podcasts, join our free newsletter here.
Don’t forget to check out our FREE Large Cap 1000 – Stock Screener, here at The Acquirer’s Multiple: